About Globomedica
Globomedica is a company based in Egg (Switzerland) founded in 2009 was acquired by The Biomedica in March 2016. Globomedica offers products and services including Pharmacare and Spezialapotheke. Globomedica operates in a competitive market with competitors including AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Akenco Pharma, among others.
- Headquarter Egg, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Globomedica Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
The Biomedica
(Mar 01, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Globomedica
Globomedica offers a comprehensive portfolio of products and services, including Pharmacare and Spezialapotheke.
Tailored solutions for pharmaceutical product distribution
Direct shipment of medications for special therapy areas
Funding Insights of Globomedica
Detailed funding history for Globomedica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Globomedica
Globomedica has secured backing from 1 investor. Prominent investors backing the company include The Biomedica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
The Biomedica is engaged in publishing open access scientific journals.
|
Locked | Locked | Locked |
Investor details for Globomedica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Globomedica
Investment portfolio details for Globomedica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Globomedica
Detailed financials for Globomedica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Globomedica Comparisons
Peer comparison for Globomedica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Globomedica
Globomedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Akenco Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Distributor of generic prescription and over-the-counter products
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
|
|
| Locked | Locked | Locked |
Distributor of drugs
|
|
| Locked | Locked | Locked |
Serves as a diversified distributor in the healthcare sector.
|
Detailed competitors of Globomedica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Globomedica
Complete news archive for Globomedica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Globomedica
Globomedica was founded in 2009.
Globomedica is headquartered in Egg, Switzerland. It is registered at Egg, Zurich, Switzerland.
Globomedica was established in 2009 and is based in Egg, Switzerland. Operations focus on the distribution of diversified pharmaceutical products within the healthcare sector. The company is led by Managing Director Peter T Vetterli. Services are facilitated through the online domain globomedica.ch, supporting logistics and supply chain needs for various drug categories in the region.
Globomedica's top competitors include AmerisourceBergen, DCS Pharma and RUWAG.
Globomedica offers Pharmacare and Spezialapotheke.
Globomedica has 1 investor. Key investors include The Biomedica.